变应性鼻炎患者求诊方式调查。

Journal of Rhinology Pub Date : 2024-11-01 Epub Date: 2024-11-30 DOI:10.18787/jr.2024.00023
Gwanghui Ryu, Do Hyun Kim, Chang Yeong Jeong, Sang Min Lee, Il Hwan Lee, Soo Whan Kim, Hyeon-Jong Yang, Mi-Ae Kim, Dong-Kyu Kim
{"title":"变应性鼻炎患者求诊方式调查。","authors":"Gwanghui Ryu, Do Hyun Kim, Chang Yeong Jeong, Sang Min Lee, Il Hwan Lee, Soo Whan Kim, Hyeon-Jong Yang, Mi-Ae Kim, Dong-Kyu Kim","doi":"10.18787/jr.2024.00023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.</p><p><strong>Methods: </strong>In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022. A questionnaire was administered to patients with confirmed allergic rhinitis to collect information regarding medical treatments (prescription and over-the-counter medication use patterns, comorbid asthma, and allergen-specific immunotherapy), environmental controls (usage of air purifiers and pet avoidance), and experiences with surgical treatments.</p><p><strong>Results: </strong>We included 51 patients with allergic rhinitis with a mean age of 31.6±16.0 years. Among them, 47 (92.2%) and 6 (11.8%) patients had pollen allergies and asthma, respectively. Furthermore, 41 (80.4%) patients took prescribed medicines, while 39 (76.5%) patients only used the medication when experiencing symptoms. Thirty patients (58.8%) reported concurrent use of intranasal sprays and oral medications. Thirty-three patients (64.7%) reported awareness of immunotherapy, and there were no preferential differences between subcutaneous (52%) and sublingual immunotherapy (48%). Of the 36 patients (70.6%) who reported using an air purifier, 38.9% considered it helpful in preventing allergic rhinitis symptoms. Fourteen patients (27.5%) currently or previously had a companion animal, with half experiencing worsening of symptoms. Twelve patients had received surgical treatment and reported high satisfaction levels (41.6%, very satisfied; 41.6%, satisfied).</p><p><strong>Conclusion: </strong>Patients with allergic rhinitis showed similar preferences for oral and spray medications. They also showed satisfaction with surgical treatments and an interest in the environmental management of allergic rhinitis.</p>","PeriodicalId":33935,"journal":{"name":"Journal of Rhinology","volume":"31 3","pages":"138-144"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685916/pdf/","citationCount":"0","resultStr":"{\"title\":\"Survey on Treatment-Seeking Patterns in Patients With Allergic Rhinitis.\",\"authors\":\"Gwanghui Ryu, Do Hyun Kim, Chang Yeong Jeong, Sang Min Lee, Il Hwan Lee, Soo Whan Kim, Hyeon-Jong Yang, Mi-Ae Kim, Dong-Kyu Kim\",\"doi\":\"10.18787/jr.2024.00023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.</p><p><strong>Methods: </strong>In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022. A questionnaire was administered to patients with confirmed allergic rhinitis to collect information regarding medical treatments (prescription and over-the-counter medication use patterns, comorbid asthma, and allergen-specific immunotherapy), environmental controls (usage of air purifiers and pet avoidance), and experiences with surgical treatments.</p><p><strong>Results: </strong>We included 51 patients with allergic rhinitis with a mean age of 31.6±16.0 years. Among them, 47 (92.2%) and 6 (11.8%) patients had pollen allergies and asthma, respectively. Furthermore, 41 (80.4%) patients took prescribed medicines, while 39 (76.5%) patients only used the medication when experiencing symptoms. Thirty patients (58.8%) reported concurrent use of intranasal sprays and oral medications. Thirty-three patients (64.7%) reported awareness of immunotherapy, and there were no preferential differences between subcutaneous (52%) and sublingual immunotherapy (48%). Of the 36 patients (70.6%) who reported using an air purifier, 38.9% considered it helpful in preventing allergic rhinitis symptoms. Fourteen patients (27.5%) currently or previously had a companion animal, with half experiencing worsening of symptoms. Twelve patients had received surgical treatment and reported high satisfaction levels (41.6%, very satisfied; 41.6%, satisfied).</p><p><strong>Conclusion: </strong>Patients with allergic rhinitis showed similar preferences for oral and spray medications. They also showed satisfaction with surgical treatments and an interest in the environmental management of allergic rhinitis.</p>\",\"PeriodicalId\":33935,\"journal\":{\"name\":\"Journal of Rhinology\",\"volume\":\"31 3\",\"pages\":\"138-144\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685916/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Rhinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18787/jr.2024.00023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rhinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18787/jr.2024.00023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:变应性鼻炎患者的首选药物及其使用尚不清楚。本研究调查了变应性鼻炎患者的就医行为,包括药物治疗、环境控制和手术治疗。方法:在本研究中,对2022年1月至2022年4月在大学医院的内科、儿科或耳鼻喉科医生进行了横断面调查。对确诊的变应性鼻炎患者进行问卷调查,以收集有关医学治疗(处方药和非处方药使用模式、共病哮喘和过敏原特异性免疫治疗)、环境控制(使用空气净化器和避免宠物)以及手术治疗经验的信息。结果:我们纳入51例变应性鼻炎患者,平均年龄31.6±16.0岁。其中花粉过敏患者47例(92.2%),哮喘患者6例(11.8%)。41例(80.4%)患者遵医嘱服药,39例(76.5%)患者仅在出现症状时服药。30例患者(58.8%)报告同时使用鼻内喷雾剂和口服药物。33名患者(64.7%)报告免疫治疗意识,皮下免疫治疗(52%)和舌下免疫治疗(48%)之间没有优先性差异。在报告使用空气净化器的36名患者(70.6%)中,38.9%的人认为它有助于预防过敏性鼻炎症状。14名患者(27.5%)目前或以前有伴侣动物,其中一半出现症状恶化。12例患者接受手术治疗,满意度较高(41.6%,非常满意;41.6%,满意)。结论:变应性鼻炎患者对口服和喷雾药物的偏好相似。他们也表现出对手术治疗的满意和对变应性鼻炎环境管理的兴趣。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Survey on Treatment-Seeking Patterns in Patients With Allergic Rhinitis.

Background and objectives: The medications preferred by patients for allergic rhinitis and their usage remain unclear. This study investigated treatment-seeking behaviors in patients with allergic rhinitis, including medical treatments, environmental controls, and surgical treatments.

Methods: In this study, a cross-sectional survey was conducted by internal medicine, pediatric, or otorhinolaryngology physicians at university hospitals from January 2022 to April 2022. A questionnaire was administered to patients with confirmed allergic rhinitis to collect information regarding medical treatments (prescription and over-the-counter medication use patterns, comorbid asthma, and allergen-specific immunotherapy), environmental controls (usage of air purifiers and pet avoidance), and experiences with surgical treatments.

Results: We included 51 patients with allergic rhinitis with a mean age of 31.6±16.0 years. Among them, 47 (92.2%) and 6 (11.8%) patients had pollen allergies and asthma, respectively. Furthermore, 41 (80.4%) patients took prescribed medicines, while 39 (76.5%) patients only used the medication when experiencing symptoms. Thirty patients (58.8%) reported concurrent use of intranasal sprays and oral medications. Thirty-three patients (64.7%) reported awareness of immunotherapy, and there were no preferential differences between subcutaneous (52%) and sublingual immunotherapy (48%). Of the 36 patients (70.6%) who reported using an air purifier, 38.9% considered it helpful in preventing allergic rhinitis symptoms. Fourteen patients (27.5%) currently or previously had a companion animal, with half experiencing worsening of symptoms. Twelve patients had received surgical treatment and reported high satisfaction levels (41.6%, very satisfied; 41.6%, satisfied).

Conclusion: Patients with allergic rhinitis showed similar preferences for oral and spray medications. They also showed satisfaction with surgical treatments and an interest in the environmental management of allergic rhinitis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
23
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信